Insider Shareholders with Direct Ownership of Poseida Therapeutics, Inc. (PSTX)
This section provides a comprehensive overview of the insiders with direct ownership of Poseida Therapeutics, Inc. (PSTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Poseida Therapeutics, Inc. Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
Malin Life Sciences Holdings Ltd
> 10% Shareholder |
2,647,548 | 0 | 11,835,673 $32.2 Million | 13 |
Aug 08, 2022
Added 15.37%
|
Pharma Ag Novartis
> 10% Shareholder |
5,908,089 | 0 | 5,908,089 $16.1 Million | 1 |
Jul 14, 2020
Added 50.0%
|
Eric Ostertag
Director |
563,241 | 105,731 | 827,320 $2.25 Million | 10 |
Feb 01, 2023
Reduced 1.4%
|
Mark J Gergen
Executive Chairman |
751,786 | 113,138 | 651,291 $1.77 Million | 6 |
Mar 01, 2024
Reduced 4.98%
|
Kristin Yarema
President and CEO |
606,836 | 0 | 606,836 $1.65 Million | 2 |
Jan 02, 2024
Added 29.18%
|
Brent Warner
President, Gene Therapy |
481,396 | 62,356 | 419,040 $1.14 Million | 5 |
Mar 01, 2024
Reduced 7.86%
|
Johanna Mylet
Chief Financial Officer |
233,959 | 22,414 | 246,283 $669,889 | 7 |
Mar 01, 2024
Reduced 6.84%
|
Harry J Leonhardt
GC & Chief Compliance Officer |
223,515 | 20,629 | 214,640 $583,820 | 5 |
Mar 01, 2024
Reduced 7.06%
|
Syed Ali Aamir Rizvi
Chief Medical Officer |
185,000 | 0 | 185,000 $503,200 | 1 |
Apr 01, 2024
Added 50.0%
|
Matthew A. Spear
Chief Medical Officer |
123,485 | 12,000 | 111,485 $303,239 | 14 |
Mar 01, 2022
Added 30.96%
|
78,600 | 0 | 78,600 $213,792 | 3 |
Jun 17, 2024
Added 20.0%
|
|
58,950 | 0 | 68,950 $187,544 | 3 |
Jun 17, 2024
Added 22.18%
|
|
58,950 | 0 | 58,950 $160,344 | 2 |
Jun 17, 2024
Added 25.0%
|
|
58,950 | 0 | 58,950 $160,344 | 3 |
Jun 17, 2024
Added 25.0%
|
|
58,950 | 0 | 58,950 $160,344 | 3 |
Jun 17, 2024
Added 25.0%
|
|
58,950 | 0 | 58,950 $160,344 | 3 |
Jun 17, 2024
Added 25.0%
|
|
Kerry D. Ingalls
Chief Operating Officer |
55,000 | 0 | 55,000 $149,600 | 3 |
Mar 16, 2022
Added 5.17%
|